| Description |
1 online resource : ill., figs., tables |
| Series |
McGraw-Hill's AccessMedicine |
|
McGraw-Hill's AccessMedicine.
|
| Contents |
INTRODUCTION -- BENEFITS, COSTS & RISKS -- PERFORMANCE OF DIAGNOSTIC TESTS -- TEST CHARACTERISTICS -- USE OF TESTS IN DIAGNOSIS & MANAGEMENT -- ODDS-LIKELIHOOD RATIOS -- REFERENCES -- INTRODUCTION -- 1. OBTAINING & HANDLING SPECIMENS -- 2. COMMONLY USED POINT-OF-CARE TESTS -- 3. PROVIDER-PERFORMED MICROSCOPY PROCEDURES -- 4. POINT-OF-CARE ULTRASOUND EXAMINATION -- REFERENCES -- HOW TO USE THIS SECTION -- ABO TYPING -- ACETAMINOPHEN -- ACETOACETATE -- ACETYLCHOLINE RECEPTOR ANTIBODIES -- ACTIVATED CLOTTING TIME -- ADRENOCORTICOTROPIC HORMONE -- ALANINE AMINOTRANSFERASE -- ALBUMIN, SERUM OR PLASMA -- ALBUMIN, URINE -- ALDOSTERONE, SERUM -- ALDOSTERONE, URINE -- ALKALINE PHOSPHATASE -- AMMONIA -- AMYLASE -- ANGIOTENSIN-CONVERTING ENZYME -- ANTIBODY SCREEN -- ANTIDIURETIC HORMONE -- ANTIGLOBULIN TEST, DIRECT -- ANTIGLOBULIN TEST, INDIRECT -- ANTITHROMBIN -- α1-ANTITRYPSIN -- ARTERIAL BLOOD GASES -- ASPARTATE AMINOTRANSFERASE -- B CELL IMMUNOGLOBULIN GENE REARRANGEMENT -- BCR/ABL, T(9;22) TRANSLOCATION BY RT-PCR -- BCR/ABL MUTATION ANALYSIS -- BETA-D-GLUCAN, SERUM -- BETA-hCG -- BILIRUBIN -- BLOOD UREA NITROGEN -- B-TYPE NATRIURETIC PEPTIDE -- BRCA1 AND BRCA2 GENOTYPING -- BRUCELLA ANTIBODY -- C-PEPTIDE -- C-REACTIVE PROTEIN, HIGH SENSITIVITY -- C1 ESTERASE INHIBITOR (C1-INH) -- CALCITONIN -- CALCIUM, SERUM OR PLASMA -- CALCIUM, IONIZED -- CALCIUM, URINE, 24-HOUR -- CALRETICULIN (CALR) MUTATION ANALYSIS -- CARBON DIOXIDE, PARTIAL PRESSURE -- CARBON DIOXIDE (TOTAL BICARBONATE) -- CARBOXYHEMOGLOBIN (COHb) -- CARCINOEMBRYONIC ANTIGEN (CEA) -- CD4 CELL COUNT -- CELIAC DISEASE (GLUTEN ENTEROPATHY), SEROLOGIC TESTING -- CENTROMERE ANTIBODIES (ACA) -- CERULOPLASMIN, SERUM OR PLASMA -- CHLORIDE -- CHOLESTEROL, SERUM OR PLASMA -- CLOSTRIDIUM DIFFICILE TOXINS -- COCCIDIOIDES ANTIBODIES -- COLD AGGLUTININS, SERUM -- COMPLEMENT C3 -- COMPLEMENT C4 -- COMPLEMENT, TOTAL (CH50) -- COMPLETE BLOOD CELL COUNT -- CORTISOL, SERUM OR PLASMA -- CORTISOL (URINARY FREE) -- COSYNTROPIN/CORTROSYN STIMULATION TEST -- CREATINE KINASE, TOTAL -- CREATINE KINASE, MB -- CREATININE, SERUM OR PLASMA -- CREATININE CLEARANCE -- CRYOGLOBULINS, QUALITATIVE, SERUM -- CRYPTOCOCCAL ANTIGEN, SERUM AND CSF -- C-TELOPEPTIDE, BETA-CROSS-LINKED (CTX-BETA) -- CYCLIC CITRULLINATED PROTEIN ANTIBODY (CCP ANTIBODY) -- CYSTATIN C -- CYTOMEGALOVIRUS ANTIBODIES (IgG AND IgM), SERUM -- D-DIMER -- DEHYDROEPIANDROSTERONE SULFATE (DHEA-S) -- DEXAMETHASONE SUPPRESSION TEST (LOW DOSE, OVERNIGHT) -- DEXAMETHASONE SUPPRESSION TEST (HIGH DOSE, OVERNIGHT) -- DOUBLE-STRANDED DNA ANTIBODY -- DRUG ABUSE SCREEN, URINE (URINE DRUG TESTING) -- EPSTEIN-BARR VIRUS ANTIBODIES (EBV ANTIBODIES) -- ERYTHROCYTE SEDIMENTATION RATE -- ERYTHROPOIETIN (EPO) -- ESTRADIOL -- ETHANOL -- FACTOR ASSAYS (COAGULATION FACTOR ASSAYS) -- FACTOR II (PROTHROMBIN) MUTATION -- FACTOR V LEIDEN MUTATION -- FACTOR VIII ASSAY -- FECAL FAT, QUANTIFICATION -- FECAL OCCULT BLOOD TESTS -- FERRITIN -- α-FETOPROTEIN (AFP) -- FIBRINOGEN (FUNCTIONAL) -- FLUORESCENT TREPONEMAL ANTIBODY-ABSORBED -- FOLIC ACID (FOLATE) -- FOLLICLE-STIMULATING HORMONE -- FRUCTOSAMINE -- GAMMA-GLUTAMYL TRANSPEPTIDASE -- GASTRIN -- GLOMERULAR FILTRATION RATE, ESTIMATED (EGFR) -- GLUCAGON -- GLUCOSE |
|
GLUCOSE TOLERANCE TEST -- G6PD (GLUCOSE-6-PHOSPHATE DEHYDROGENASE) -- GROWTH HORMONE -- HAPTOGLOBIN -- HELICOBACTER PYLORI TESTS -- HEMATOCRIT -- HEMOGLOBIN A1C, BLOOD -- HEMOGLOBIN A2 -- HEMOGLOBIN ELECTROPHORESIS AND EVALUATION -- HEMOGLOBIN, FETAL -- HEMOGLOBIN, TOTAL -- HEPARIN ANTI-XA ASSAY, CHROMOGENIC -- HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) ANTIBODIES -- HEPATITIS A VIRUS ANTIBODY -- HEPATITIS B SURFACE ANTIGEN -- HEPATITIS B SURFACE ANTIBODY -- HEPATITIS B CORE ANTIBODY -- HEPATITIS B E ANTIGEN -- HEPATITIS B VIRUS DNA, QUANTITATIVE -- HEPATITIS C VIRUS ANTIBODY -- HEPATITIS C VIRUS GENOTYPING -- HEPATITIS C VIRUS RNA (HCV-RNA), QUANTITATIVE -- HEPATITIS DELTA ANTIBODY -- HEPATITIS E VIRUS ANTIBODY -- HETEROPHILE ANTIBODY -- HISTOPLASMA CAPSULATUM ANTIGEN -- HISTOPLASMA CAPSULATUM ANTIBODIES BY IMMUNODIFFUSION -- HISTOPLASMA CAPSULATUM ANTIBODIES BY CF -- HIV ANTIBODY -- HIV RNA, QUANTITATIVE -- HIV RESISTANCE TESTING -- HLA TYPING -- HLA-B27 TYPING -- HLA-B51 TYPING -- HOMOCYSTEINE -- 5-HYDROXYINDOLEACETIC ACID -- IGG INDEX -- INCREASE IN IGG4: -- IMMUNOFIXATION ELECTROPHORESIS -- IMMUNOGLOBULINS -- INHIBITOR SCREEN (1:1 MIX) -- INSULIN ANTIBODY -- INSULIN, IMMUNOREACTIVE -- INSULIN-LIKE GROWTH FACTOR-1 -- INTRINSIC FACTOR BLOCKING ANTIBODY -- IODINE -- IRON -- IRON-BINDING CAPACITY -- ISLET CELL ANTIBODIES -- JAK2 (V617F) MUTATION -- KAPPA AND LAMBDA FREE LIGHT CHAINS WITH RATIO -- LACTATE DEHYDROGENASE -- LACTATE -- LEAD -- LEGIONELLA ANTIBODY -- LEUKEMIA/LYMPHOMA PHENOTYPING BY FLOW CYTOMETRY -- LIPASE -- LIPOPROTEIN(A) -- LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) -- LUTEINIZING HORMONE -- LYME DISEASE ANTIBODY -- MAGNESIUM -- MEAN CORPUSCULAR HEMOGLOBIN -- MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION -- MEAN CORPUSCULAR VOLUME -- METANEPHRINES, FREE (UNCONJUGATED), PLASMA -- METANEPHRINES, FRACTIONATED, URINE -- METHANOL -- METHEMOGLOBIN -- MTHFR MUTATION -- METHYLMALONIC ACID -- β2-MICROGLOBULIN -- MITOCHONDRIAL ANTIBODIES -- NEUTROPHIL CYTOPLASMIC ANTIBODIES -- N-TELOPEPTIDE, CROSS-LINKED -- NUCLEAR ANTIBODY -- OLIGOCLONAL BANDS -- OSMOLALITY, SERUM -- OSMOLALITY, URINE -- OSTEOCALCIN -- OXYGEN, PARTIAL PRESSURE -- PANCREATIC ELASTASE -- PARATHYROID HORMONE -- PARATHYROID HORMONE-RELATED PROTEIN -- PARTIAL THROMBOPLASTIN TIME -- pH -- PHOSPHORUS -- PLATELET ANTIBODIES -- PLATELET COUNT -- PLATELET FUNCTION ASSAY -- PORPHOBILINOGEN -- POTASSIUM -- PROCALCITONIN -- PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE (PINP) -- PROLACTIN -- PROSTATE-SPECIFIC ANTIGEN -- PROTEIN C -- PROTEIN ELECTROPHORESIS -- PROTEIN S -- PROTEIN, TOTAL -- PROTHROMBIN TIME -- Q FEVER ANTIBODY -- QUANTIFERON-TB (INTERFERON-GAMMA RELEASING ASSAY) -- RAPID PLASMA REAGIN -- RED BLOOD CELL COUNT -- RENIN ACTIVITY -- RETICULOCYTE COUNT -- Rh(D) TYPING -- RHEUMATOID FACTOR -- RIBONUCLEOPROTEIN ANTIBODY -- RIBOSOMAL DNA (16S rDNA) SEQUENCING -- RUBELLA ANTIBODY -- RUSSELL VIPER VENOM TIME (dRVVT) -- SALICYLATE -- SCLERODERMA-ASSOCIATED ANTIBODY -- SEMEN ANALYSIS -- SMITH (ANTI-Sm) ANTIBODY -- SMOOTH MUSCLE ANTIBODIES -- SODIUM -- SOMATOSTATIN -- SS-A/Ro ANTIBODY -- SS-B/La ANTIBODY -- SYPHILIS, SEROLOGIC TESTING -- T-CELL RECEPTOR GENE REARRANGEMENT -- TESTOSTERONE |
|
THROMBIN TIME -- THYROGLOBULIN -- THYROGLOBULIN ANTIBODY -- THYROID PEROXIDASE ANTIBODY -- THYROID-STIMULATING HORMONE -- THYROID STIMULATING IMMUNOGLOBULIN -- THYROXINE, TOTAL -- THYROXINE, FREE -- TOXOPLASMA ANTIBODY -- TRANSFERRIN -- TRANSFERRIN RECEPTOR, SOLUBLE -- TREPONEMA PALLIDUM ANTIBODY -- TRIGLYCERIDES -- TRIIODOTHYRONINE -- TROPONIN-I, CARDIAC -- TULAREMIA AGGLUTININS -- TYPE AND CROSSMATCH -- TYPE AND SCREEN -- URIC ACID -- VANILLYLMANDELIC ACID -- VDRL TEST, SERUM -- VITAMIN B12 -- VITAMIN D, 25-HYDROXY -- VITAMIN D, 1,25-DIHYDROXY -- von WILLEBRAND FACTOR -- WHITE BLOOD CELL COUNT AND DIFFERENTIAL -- ZINC PROTOPORPHYRIN (ZPP) -- UNDERLYING ASSUMPTIONS -- INDICATIONS FOR DRUG MONITORING -- SITUATIONS IN WHICH DRUG MONITORING MAY NOT BE USEFUL -- OTHER INFORMATION REQUIRED FOR EFFECTIVE DRUG MONITORING -- PHARMACOKINETIC PARAMETERS -- GENETIC INFLUENCES ON THERAPEUTIC DRUG RESPONSE -- CLINICAL USE OF PHARMACOGENETIC TESTING -- REFERENCES -- HOW TO USE THIS SECTION -- BRAIN ABSCESS -- ENCEPHALITIS -- ASEPTIC MENINGITIS -- BACTERIAL MENINGITIS -- FUNGAL MENINGITIS -- SPIROCHETAL MENINGITIS/NEUROLOGIC DISEASES -- PARASITIC MENINGOENCEPHALITIS -- TUBERCULOUS MENINGITIS -- CONJUNCTIVITIS -- KERATITIS -- ENDOPHTHALMITIS -- OTITIS MEDIA -- OTITIS EXTERNA -- SINUSITIS -- PHARYNGITIS -- LARYNGITIS -- LARYNGOTRACHEOBRONCHITIS -- EPIGLOTTITIS -- COMMUNITY-ACQUIRED PNEUMONIA -- ANAEROBIC PNEUMONIA -- HOSPITAL-ACQUIRED PNEUMONIA -- PNEUMONIA IN IMMUNOCOMPROMISED HOST -- MYCOBACTERIAL PNEUMONIA -- EMPYEMA -- PERICARDITIS -- TUBERCULOUS PERICARDITIS -- INFECTIOUS MYOCARDITIS -- INFECTIVE ENDOCARDITIS -- INFECTIOUS THROMBOPHLEBITIS -- GASTRITIS -- INFECTIOUS ESOPHAGITIS -- INFECTIOUS COLITIS/DYSENTERY -- ANTIBIOTIC-ASSOCIATED COLITIS -- DIARRHEA IN HIV -- PERITONITIS -- TUBERCULOUS PERITONITIS/ENTEROCOLITIS -- DIVERTICULITIS -- LIVER ABSCESS -- CHOLANGITIS/CHOLECYSTITIS -- URINARY TRACT INFECTION -- PROSTATITIS -- PYELONEPHRITIS -- PERINEPHRIC ABSCESS -- URETHRITIS -- EPIDIDYMITIS/ORCHITIS -- VAGINITIS/VAGINOSIS -- CERVICITIS -- SALPINGITIS -- CHORIOAMNIONITIS/ENDOMETRITIS -- OSTEOMYELITIS -- BACTERIAL/SEPTIC ARTHRITIS -- GAS GANGRENE -- IMPETIGO -- CELLULITIS -- BACTEREMIA OF UNKNOWN SOURCE -- ACINETOBACTER -- AVIAN INFLUENZA A/H5N1, AVIAN INFLUENZA A/H7N9, AND NOVEL H1N1 INFLUENZA A -- CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE) -- CHIKUNGUNYA VIRUS -- CLOSTRIDIUM DIFFICILE -- CRYPTOCOCCUS GATTII -- DENGUE VIRUS -- EBOLA VIRUS -- ESCHERICHIA COLI, DIARRHEAGENIC -- E. COLI, DIFFUSELY ADHERENT (DAEC) -- E. COLI, ENTEROAGGREGATIVE (EAEC) -- E. COLI, ENTEROHEMORRHAGIC/SHIGA-TOXIN-PRODUCING E. COLI (EHEC/STEC) -- E. COLI, ENTEROINVASIVE (EIEC) -- E. COLI, ENTEROPATHOGENIC (EPEC) -- E. COLI, ENTEROTOXIGENIC (ETEC) -- HUMAN GRANULOCYTOTROPIC ANAPLASMOSIS (HGA) -- HUMAN METAPNEUMOVIRUS (huMPV) -- HUMAN MONKEYPOX VIRUS -- HUMAN MONOCYTIC EHRLICHIOSIS (HME) -- LYME DISEASE -- METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) -- MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV) -- MUMPS -- SEVERE ACUTE RESPIRATORY SYNDROME-CORONAVIRUS A (SARS-CoA) -- STREPTOCOCCUS PNEUMONIAE, RESISTANT -- TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY (TSE) -- WEST NILE VIRUS (WNV) -- VANCOMYCIN-RESISTANT ENTEROCOCCUS (VRE) -- ZIKA VIRUS -- HOW TO USE THIS SECTION -- RISKS OF IODINATED CT INTRAVENOUS CONTRAST AGENTS -- RISKS OF GADOLINIUM-BASED MRI INTRAVENOUS CONTRAST AGENTS |
|
I. BASIC ELECTROCARDIOGRAPHY -- STEP ONE: DIAGNOSIS OF THE CARDIAC RHYTHM -- MORPHOLOGY ALGORITHMS FOR IDENTIFYING VT -- STEP TWO: MORPHOLOGIC DIAGNOSIS OF THE CARDIAC WAVEFORMS -- II. BASIC ECHOCARDIOGRAPHY -- REFERENCES -- HOW TO USE THIS SECTION -- ACID-BASE DISTURBANCE: LABORATORY CHARACTERISTICS OF PRIMARY OR SINGLE ACID-BASE DISTURBANCE -- ANEMIA: DIAGNOSIS OF COMMON ANEMIAS BASED ON RED CELL INDICES -- ANEMIA: LABORATORY EVALUATION OF MICROCYTIC, HYPOCHROMIC ANEMIAS -- ANTICOAGULANTS: MECHANISM OF ACTION, CLINICAL INDICATIONS, AND LABORATORY MONITORING -- ARTHRITIS: EXAMINATION AND CLASSIFICATION OF SYNOVIAL (JOINT) FLUID -- ASCITES: ASCITIC FLUID PROFILES IN VARIOUS DISEASE STATES -- AUTOANTIBODIES: FREQUENCY (%) OF AUTOANTIBODIES IN RHEUMATIC DISEASES -- BLEEDING DISORDERS: LABORATORY EVALUATION -- CEREBROSPINAL FLUID (CSF): CSF PROFILES IN CENTRAL NERVOUS SYSTEM DISEASES -- CIRRHOSIS: CHILD-PUGH STAGES AND MODEL FOR END-STAGE LIVER DISEASE (MELD) SCORING SYSTEM -- GENETIC DISEASES: MOLECULAR DIAGNOSTIC TESTING -- HEPATITIS B VIRUS INFECTION: COMMON SEROLOGIC TEST PATTERNS AND THEIR INTERPRETATION -- LEUKEMIAS AND LYMPHOMAS: CLASSIFICATION AND IMMUNOPHENOTYPING -- OSMOL GAP: CALCULATION AND APPLICATION IN CLINICAL TOXICOLOGY -- RANSON CRITERIA FOR ASSESSING SEVERITY OF ACUTE PANCREATITIS -- PLEURAL EFFUSION: PLEURAL FLUID PROFILES IN VARIOUS DISEASE STATES -- PRENATAL DIAGNOSTIC METHODS: AMNIOCENTESIS, CHORIONIC VILLUS SAMPLING, AND CORDOCENTESIS -- PULMONARY FUNCTION TESTS: INTERPRETATION IN OBSTRUCTIVE AND RESTRICTIVE PULMONARY DISEASES -- RENAL FAILURE: CLASSIFICATION AND DIFFERENTIAL DIAGNOSIS -- RENAL TUBULAR ACIDOSIS (RTA): LABORATORY DIAGNOSIS -- SYPHILIS: CLINICAL AND LABORATORY DIAGNOSIS IN UNTREATED PATIENTS -- THALASSEMIA SYNDROMES: GENETICS AND LABORATORY CHARACTERISTICS -- TRANSFUSION: SUMMARY CHART OF BLOOD COMPONENT THERAPY -- VALVULAR HEART DISEASE: DIAGNOSTIC EVALUATION -- HOW TO USE THIS SECTION -- ACID-BASE DISTURBANCES: DIAGNOSTIC APPROACH -- ADRENAL MASS: DIAGNOSTIC EVALUATION -- ADRENOCORTICAL INSUFFICIENCY (HYPOCORTISOLISM): LABORATORY EVALUATION OF SUSPECTED ADRENOCORTICAL INSUFFICIENCY (HYPOCORTISOLISM) -- AMENORRHEA OR OLIGOMENORRHEA: DIAGNOSTIC LABORATORY EVALUATION FOR AMENORRHEA OR OLIGOMENORRHEA -- ANEMIA: GENERAL CONSIDERATIONS AND INITIAL EVALUATION -- ASCITES: DIAGNOSTIC EVALUATION -- BLEEDING DISORDERS, INHERITED: EVALUATION OF SUSPECTED INHERITED BLEEDING DISORDERS -- CUSHING SYNDROME (HYPERCORTISOLISM): DIAGNOSTIC EVALUATION OF SUSPECTED CUSHING SYNDROME (HYPERCORTISOLISM) -- GOITER: DIAGNOSTIC EVALUATION AND MANAGEMENT STRATEGY -- HEMOCHROMATOSIS: DIAGNOSTIC EVALUATION OF SUSPECTED HEMOCHROMATOSIS -- HCV INFECTION: DIAGNOSTIC STRATEGY FOR PATIENTS WITH SUSPECTED HCV INFECTION -- HIV INFECTION: DIAGNOSTIC STRATEGY FOR PATIENTS WITH SUSPECTED HIV INFECTION -- HIRSUTISM: EVALUATION OF HIRSUTISM IN FEMALES -- HYPERALDOSTERONISM: LABORATORY EVALUATION OF SUSPECTED HYPERALDOSTERONISM -- HYPERCALCEMIA: DIAGNOSTIC APPROACH TO HYPERCALCEMIA -- HYPERTHYROIDISM: LABORATORY EVALUATION -- HYPOCALCEMIA: DIAGNOSTIC APPROACH TO HYPOCALCEMIA -- HYPONATREMIA: EVALUATION OF HYPONATREMIA |
|
HYPOTHYROIDISM: DIAGNOSTIC APPROACH -- INFERTILITY, FEMALE: EVALUATION OF FEMALE INFERTILITY -- INFERTILITY, MALE: EVALUATION OF MALE FACTOR INFERTILITY -- JAUNDICE: GENERAL CONSIDERATIONS AND INITIAL LABORATORY EVALUATION -- LYMPHOCYTOSIS: GENERAL APPROACH TO ESTABLISHED LYMPHOCYTOSIS -- MONOARTHRITIS, ACUTE: EVALUATION OF ACUTE MONOARTHRITIS -- PHEOCHROMOCYTOMA: EVALUATION AND LOCALIZATION OF A POSSIBLE PHEOCHROMOCYTOMA -- POLYCYTHEMIA: DIAGNOSTIC EVALUATION -- PORPHYRIA, ACUTE: LABORATORY EVALUATION OF SUSPECTED ACUTE NEUROVISCERAL OR NEUROCUTANEOUS PORPHYRIA -- ISOLATED PROLONGATION OF PTT: LABORATORY EVALUATION -- PULMONARY EMBOLISM: DIAGNOSTIC STRATEGY FOR PATIENTS WITH SUSPECTED PULMONARY EMBOLISM -- SLEEP DISTURBANCE: DIAGNOSTIC EVALUATION -- SYPHILIS SEROLOGIC TESTING: TWO COMMONLY USED APPROACHES TO THE SEROLOGICAL DIAGNOSIS OF SYPHILIS -- THROMBOCYTOPENIA, ACQUIRED: DIAGNOSTIC APPROACH TO ACQUIRED THROMBOCYTOPENIA -- THROMBOCYTOSIS: DIAGNOSTIC EVALUATION OF SUSTAINED THROMBOCYTOSIS -- THROMBOSIS, VENOUS: EVALUATION FOR POSSIBLE HYPERCOAGULABILITY (THROMBOPHILIA) CAUSING VENOUS THROMBOSIS -- THYROID NODULE: DIAGNOSTIC EVALUATION -- TRANSFUSION: BLOOD DONATION AND PREPARATION OF BLOOD COMPONENTS -- HOW TO USE THIS SECTION -- ACID-BASE NOMOGRAM -- COAGULATION CASCADE -- COMPLEMENT SYSTEM -- DERMATOME CHART -- HEPATITIS A SEROLOGIC CHANGES -- HEPATITIS B SEROLOGIC CHANGES -- HEPATITIS C SEROLOGY AND VIRAL LOAD -- PARATHYROID HORMONE AND CALCIUM NOMOGRAM -- PULMONARY FUNCTION TESTS: SPIROMETRY -- STEROIDOGENESIS PATHWAY |
| Bibliography |
Includes bibliographical references and indexes |
| Notes |
Also issued in Online and PDF version |
|
Description based on cover image and table of contents, viewed on Mar. 06, 2017 |
| Subject |
Diagnosis, Laboratory -- Handbooks, manuals, etc.
|
|
Diagnostic imaging -- Handbooks, manuals, etc.
|
|
Clinical Laboratory Techniques
|
|
Diagnosis, Differential.
|
|
Diagnostic Imaging
|
|
Diagnostic Tests, Routine
|
|
Diagnostic Tests, Routine.
|
| Reading List |
HMP703 recommended text 2024
|
|
HMP709 recommended text 2024
|
| Form |
Electronic book
|
| Author |
Nicoll, Diana, ed.
|
|
Lu, Chuanyi Mark, ed.
|
|
McPhee, Stephen J., ed.
|
| ISBN |
9781259640896 (print-ISBN) |
|
1259640892 (print-ISBN) |
|
9781259640902 (e-ISBN) |
|
1259640906 (e-ISBN) |
|
